Novo Nordisk

Tresiba significantly lowers hypo rates

13th June 2016

New results from two Phase 3b trials have shown people with type 1 and type 2 diabetes  treated with Tresiba® (insulin degludec) experienced significantly lower rates of several types of ...

Read more

Novo publishes hypo resources

13th June 2016

A new resource hub has been released by Novo Nordisk to support people with diabetes. It has been created to help people to better understand the often misunderstood signs and long-term impact of ...

Read more

Type 2 ‘cost effective’ drug unveiled

3rd March 2016

Xultophy (IDegLira) has been found to be more cost-effective when compared with current basal insulin intensification in people with uncontrolled type 2 diabetes. The findings of the once-daily ...

Read more

Clinical champion recruitment drive starts

18th February 2016

Healthcare professionals who have experience in treating diabetes are being asked to sign up as local volunteers to help with the “diabetes crisis”. Leading charity Diabetes UK is ...

Read more

Hospitals support Hypo Awareness Week

8th October 2015

A total of 126 hospitals across the country are currently taking part in a national campaign to raise awareness of hypoglycaemia. Hypo Awareness Week 2015, which began on Monday, October 5, and ...

Read more

Date for Hypo Awareness Week 2015

16th July 2015

Hypo Awareness Week 2015 will take place from October  5 to 11, it has been announced. The campaign raises awareness of hypoglycaemia in the inpatient setting with the aim of helping hospital ...

Read more